Neurovance Lands $3,000,000 New Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=08ee848c-7af2-4887-a7c3-a530d7f6d8f3&Preview=1 -
Date
10/16/2012 -
Company Name
Neurovance -
Mailing Address
43 Thorndike Street Cambridge, MA 02141 -
Company Description
Neurovance is a stealth pharmaceutical company developing pharmaceutical preparations for the treatment of disorder of the central nervous system. -
Website
Undisclosed
-
Transaction Type
Debt -
Transaction Amount
$3,000,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
The offering will close in 3 separate tranches if certain milestones are met. The first tranche of $3,000,000 closed 10/11/12. SEC regulatory filing. -
M&A Terms
-
Venture Investor
Undisclosed
